Видео с ютуба Dr. Joshua Meeks

Predicting Which Bladder Cancer Patients Will Respond to Immunotherapy

FDA Approves Practice-Changing Novel Therapy for Bladder Cancer

Predicting Which Bladder Cancer Patients Will Respond to Immunotherapy

Challenging Cases in Non-Muscle Invasive Bladder Cancer (NMIBC) – Drs. Shilpa Gupta & Joshua Meeks

Dr. Meeks on the Genomics of Bladder Cancer

Clinical Integration of Bladder Cancer Care at Northwestern Medicine

Clinical Integration of Bladder Cancer Care at Northwestern Medicine

Addressing the BCG Shortage in Bladder Cancer Care at Northwestern Medicine

Copy of Dr. Meeks on the Genomics of Bladder Cancer

Intermediate Risk Bladder Cancer: Understanding Your Treatment Options. Part 2 of 4

Update on First Biomarker-Directed Trial of Non-Muscle-Invasive Bladder Cancer

Intermediate Risk Bladder Cancer: Understanding Your Treatment Options. Part 4 of 4

Intermediate Risk Bladder Cancer: Understanding Your Treatment Options. Part 3 of 4

Investigating and Reducing Gender Disparities in Bladder Cancer

Practice-Changing Articles in Bladder Cancer

Intermediate Risk Bladder Cancer: Understanding Your Treatment Options. Part 1 of 4

Practice-Changing Articles in Bladder Cancer

Finding Information About Your Diagnosis and Researching Your Doctor

Friends remember the impact Joshua Meeks had on lives in such a short amount of time. 2/4

Seeking Second Opinions And Managing Expectations with Recurrences